Psychobiological model of personality and psychopharmacotherapy outcomes in treatment of depression and schizophrenia.

In distinguishing why some patients respond and other do not respond to treatments arraised the clinically very important body of research considering weather patients' personality characteristics might predict outcomes of pharmacotherapeutic treatment. Personality can be a predictor of a psychiatric disorder either owing to their common genetic background or because it enhances exposure of the subject to environmental risk factors. The results of the studies using psychobiological model are reviewed. The studies show that personality temperament dimension Harm Avoidance and character dimension Self-directedness predict outcomes of the pharmacological treatment of depression, but the result for other psychiatric disorders are sparse. The studies are not straightforward in recommendations for treatment choice dependent of personality dimensions.

• Publication year

  2013

• Venue

  Psychiatria Danubina

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 24048406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Personality traits, interpersonal problems and therapeutic alliance in early schizophrenia spectrum disorders.

  2013cited by this paper
• Does personality play a relevant role in the placebo effect?

  2013cited by this paper
• Predicting depression with temperament and character in lung cancer patients.

  2013cited by this paper
• Placebo analgesia: cognitive influences on therapeutic outcome

  2012cited by this paper
• A meta-analysis of temperament in axis I psychiatric disorders.

  2012cited by this paper
• Can onset and recovery in depression be predicted by temperament? A systematic review and meta-analysis.

  2011cited by this paper
• Novelty seeking and medication adherence in patients with schizophrenia.

  2011cited by this paper
• The influence of personality traits and beliefs about medicines on adherence to asthma treatment.

  2011cited by this paper
• Economic impact of nonpersistence with antidepressant treatment in the adult population of Quebec: a comparative cost-effectiveness approach.

  2011cited by this paper
• Relations of internalized stigma with temperament and character in patients with schizophrenia.

  2010cited by this paper
• Inter-individual differences in neurobiology as vulnerability factors for affective disorders: implications for psychopharmacology.

  2010cited by this paper
• Measures of temperament and character are differentially impacted on by depression severity.

  2010cited by this paper
• Harm Avoidance as a Mediator of Treatment Response to Antidepressant Treatment of Patients with Major Depression

  2010cited by this paper
• The Anatomy of the Mesolimbic Reward System: A Link between Personality and the Placebo Analgesic Response

  2009cited by this paper
• Eighteen months of drug treatment for depression: predicting relapse and recovery.

  2009influential reference
• Moderation of antidepressant response by the serotonin transporter gene

  2009cited by this paper
• Hypomanic, cyclothymic and hostile personality traits in bipolar spectrum illness: a family-based study.

  2008cited by this paper
• Placebo effects: clinical aspects and neurobiology.

  2008cited by this paper
• Anorexia nervosa trios: behavioral profiles of individuals with anorexia nervosa and their parents

  2008cited by this paper
• Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data.

  2008cited by this paper
• Individual differences in reward responding explain placebo-induced expectations and effects.

  2007cited by this paper
• Understanding and addressing adherence issues in schizophrenia: from theory to practice.

  2007cited by this paper
• Temperament and character personality profiles and personality disorders in chronic pain patients

  2007cited by this paper
• Can personality assessment predict future depression? A twelve-month follow-up of 631 subjects.

  2006cited by this paper
• The molecular genetic architecture of human personality: beyond self-report questionnaires

  2006cited by this paper
• Genetic bases for endophenotypes in psychiatric disorders

  2005cited by this paper
• Health and Quality of Life Outcomes

  2004cited by this paper
• Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia.

  2004cited by this paper
• A sib-pair study of the Temperament and Character Inventory scales in major depression.

  2003cited by this paper
• Early and delayed personality changes associated with depression recovery? A one-year follow-up study.

  2002cited by this paper
• Comparison of the effects of fluoxetine, imipramine and placebo on personality in atypical depression.

  2002cited by this paper
• Placebo response in studies of major depression: variable, substantial, and growing.

  2002cited by this paper
• Personality pathology and treatment outcome in major depression: a review.

  2002cited by this paper
• Association between temperamental characteristics and medication adherence in subjects presenting with psychotic or mood disorders.

  2001cited by this paper
• Relation among dopamine D(2) receptor binding, obesity and personality in normal human subjects.

  2001cited by this paper
• Tridimensional personality questionnaire and treatment response in major depressive disorder: a negative study.

  2000cited by this paper
• Personality and clinical predictors of recurrence of depression.

  1999cited by this paper
• Temperament and character inventory dimensions as a predictor of response to antidepressant treatment in major depression.

  1999cited by this paper
• The Big Five Trait taxonomy: History, measurement, and theoretical perspectives.

  1999cited by this paper
• Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol.

  1997cited by this paper
• Exploring the TPQ as a possible predictor of antidepressant response to nefazodone in a large multi-site study.

  1997cited by this paper
• Genetic and environmental structure of the Tridimensional Personality Questionnaire: three or four temperament dimensions?

  1996cited by this paper
• Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking

  1996cited by this paper
• Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking

  1996cited by this paper
• Affective state dependence of the Tridimensional Personality Questionnaire.

  1995cited by this paper
• The tridimensional personality questionnaire as a predictor of response to nefazodone treatment of depression.

  1995cited by this paper
• The temperament and character inventory (TCI) : a guide to its development and use

  1994cited by this paper
• Personality pathology and response to somatic treatments for major depression: A critical review

  1994cited by this paper
• Testing a model for the genetic structure of personality: a comparison of the personality systems of Cloninger and Eysenck.

  1994cited by this paper
• Temperament predicts clomipramine and desipramine response in major depression.

  1994cited by this paper
• Relationships of the Tridimensional Personality Questionnaire to Mood and Personality Measures for Depressed Patients

  1994cited by this paper
• The Tridimensional Personality Questionnaire as a predictor of six-month outcome in first episode mania.

  1993cited by this paper
• A psychobiological model of temperament and character.

  1993cited by this paper
• The Tridimensional Personality Questionnaire in major depression.

  1993cited by this paper
• The relationship of personality to mood and anxiety states: a dimensional approach.

  1992cited by this paper
• Personality: Theory and research, 7th ed.

  1989cited by this paper
• A systematic method for clinical description and classification of personality variants. A proposal.

  1987cited by this paper
• Sensation seeking in England and America: cross-cultural, age, and sex comparisons.

  1978cited by this paper

• Personality traits in psychotic illness and their clinical correlates: A systematic review.

  2023cites this paper
• Personality as a basis for antidepressant selection for patients with depression: A two-point outcome study at 4 and 8 weeks.

  2022cites this paper
• Heritability and familiality of psychopathologic dimensions in Korean families with schizophrenia

  2019cites this paper
• Personality and Brain Disorders: Associations and Interventions

  2019cites this paper
• Transmissibility and familiality of NEO personality dimensions in a sample of Korean families with schizophrenia

  2018cites this paper
• Personality Characteristics as Predictive Factors for the Occurrence of Depressive Disorder

  2017cites this paper
• Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia

  2017cites this paper
• Heritability and Familiality of Temperament and Character Dimensions in Korean Families with Schizophrenic Linkage Disequilibrium

  2016cites this paper
• The relationship between temperament and serum serotonin concentration in migraine without aura

  2016influential citation
• Childhood Trauma, Temperament, and Character in Subjects With Major Depressive Disorder and Bipolar Disorder

  2014influential citation
• Self-directedness: an indicator for clinical response to the HF-rTMS treatment in refractory melancholic depression.

  2014cites this paper
• The placebo-nocebo response: controversies and challenges from clinical and research perspective.

  2014cites this paper
• Parkinsonian motor impairment predicts personality domains Parkinsonian motor impairment predicts personality domains related to genetic risk and treatment outcomes in schizophrenia related to genetic risk and treatment outcomes in schizophrenia

  year unknowncites this paper